PDB Short entry for 1T34 HEADER SIGNALING PROTEIN,MEMBRANE PROTEIN 23-APR-04 1T34 TITLE ROTATION MECHANISM FOR TRANSMEMBRANE SIGNALING BY THE ATRIAL TITLE 2 NATRIURETIC PEPTIDE RECEPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATRIAL NATRIURETIC PEPTIDE RECEPTOR A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HORMONE BINDING DOMAIN (RESIDUES 1-435); COMPND 5 SYNONYM: ANP-A; ANPRA; GC-A; GUANYLATE CYCLASE; NPR-A; ATRIAL COMPND 6 NATRIURETIC PEPTIDE A-TYPE RECEPTOR; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ATRIAL NATRIURETIC PEPTIDE FACTOR; COMPND 10 CHAIN: H; COMPND 11 FRAGMENT: RESIDUES 129-149; COMPND 12 SYNONYM: ANF; ANP; PREPRONATRIODILATIN; ATRIAL NATRIURETIC PEPTIDE; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: NPR1; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_CELL: BABY HAMPSTER KIDNEY CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCDNA3-NPRA-ECD; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: THIS SEQUENCE OCCURS IN RATTUS NORVEGICUS KEYWDS RECEPTOR-HORMONE COMPLEX; NATRIURETIC PEPTIDE RECEPTOR; GUANYLYL- KEYWDS 2 CYCLASE-COUPLED RECEPTOR; SIGNAL TRANSDUCTION; ROTATION MECHANISM, KEYWDS 3 SIGNALING PROTEIN, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.OGAWA,Y.QIU,C.M.OGATA,K.S.MISONO REVDAT 6 23-AUG-23 1T34 1 HETSYN REVDAT 5 29-JUL-20 1T34 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 24-JUL-19 1T34 1 REMARK LINK REVDAT 3 13-JUL-11 1T34 1 VERSN REVDAT 2 24-FEB-09 1T34 1 VERSN REVDAT 1 03-AUG-04 1T34 0 JRNL AUTH H.OGAWA,Y.QIU,C.M.OGATA,K.S.MISONO JRNL TITL CRYSTAL STRUCTURE OF HORMONE-BOUND ATRIAL NATRIURETIC JRNL TITL 2 PEPTIDE RECEPTOR EXTRACELLULAR DOMAIN: ROTATION MECHANISM JRNL TITL 3 FOR TRANSMEMBRANE SIGNAL TRANSDUCTION JRNL REF J.BIOL.CHEM. V. 279 28625 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15117952 JRNL DOI 10.1074/JBC.M313222200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.OGAWA,X.ZHANG,Y.QIU,C.M.OGATA,K.S.MISONO REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS OF ATRIAL REMARK 1 TITL 2 NATRIURETIC PEPTIDE (ANP) RECEPTOR EXTRACELLULAR DOMAIN REMARK 1 TITL 3 COMPLEX WITH ANP: USE OF AMMONIUM SULFATE AS THE CRYOSALT REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 59 1831 2003 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444903016445 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.QIU,H.OGAWA,M.MIYAGI,K.S.MISONO REMARK 1 TITL CONSTITUTIVE ACTIVATION AND UNCOUPLING OF THE ATRIAL REMARK 1 TITL 2 NATRIURETIC PEPTIDE RECEPTOR BY MUTATIONS AT THE DIMER REMARK 1 TITL 3 INTERFACE: ROLE OF DIMER INTERFACE IN SIGNALING REMARK 1 REF J.BIOL.CHEM. V. 279 6115 2004 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M310225200 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 3 NUMBER OF REFLECTIONS : 25503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.700 REMARK 3 FREE R VALUE TEST SET COUNT : 2123 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2039 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2690 REMARK 3 BIN FREE R VALUE SET COUNT : 168 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6818 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 114 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.48000 REMARK 3 B22 (A**2) : 0.48000 REMARK 3 B33 (A**2) : -0.72000 REMARK 3 B12 (A**2) : 0.24000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.445 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.378 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 20.514 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7280 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9910 ; 1.550 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 884 ; 3.161 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1090 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5586 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3436 ; 0.243 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 220 ; 0.145 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.203 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4418 ; 1.559 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7090 ; 2.940 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2862 ; 2.478 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2820 ; 3.549 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T34 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000022251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979338 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25503 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 87.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.55400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1DP4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, SODIUM CHLORIDE, PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.60100 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 173.20200 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 129.90150 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 216.50250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 43.30050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 427 REMARK 465 GLU A 428 REMARK 465 ASP A 429 REMARK 465 PRO A 430 REMARK 465 ALA A 431 REMARK 465 CYS A 432 REMARK 465 ASN A 433 REMARK 465 GLN A 434 REMARK 465 ASP A 435 REMARK 465 GLY B 253 REMARK 465 LEU B 254 REMARK 465 VAL B 255 REMARK 465 PRO B 256 REMARK 465 ASP B 426 REMARK 465 ASN B 427 REMARK 465 GLU B 428 REMARK 465 ASP B 429 REMARK 465 PRO B 430 REMARK 465 ALA B 431 REMARK 465 CYS B 432 REMARK 465 ASN B 433 REMARK 465 GLN B 434 REMARK 465 ASP B 435 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 62 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 267 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP A 419 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 156 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 382 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 419 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ARG H 11 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG H 11 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG H 27 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 12 -43.64 -139.15 REMARK 500 TYR A 120 58.37 -95.11 REMARK 500 LEU A 122 13.94 59.01 REMARK 500 HIS A 148 -70.87 -137.64 REMARK 500 ASP A 156 139.43 -178.68 REMARK 500 ARG A 157 -167.41 -64.17 REMARK 500 ASP A 160 -168.50 -162.38 REMARK 500 ASN A 180 -14.97 64.40 REMARK 500 GLU A 261 110.55 -39.83 REMARK 500 PHE A 274 4.61 -62.46 REMARK 500 ASP A 367 -169.88 -78.16 REMARK 500 ASP A 419 16.21 -69.82 REMARK 500 THR B 12 -37.54 -135.71 REMARK 500 LEU B 41 75.33 44.86 REMARK 500 ARG B 101 36.50 70.31 REMARK 500 LYS B 117 -72.06 -42.58 REMARK 500 TYR B 120 51.47 -110.45 REMARK 500 HIS B 148 -80.23 -128.94 REMARK 500 ASP B 160 -160.86 -112.93 REMARK 500 ARG B 208 -50.88 -122.02 REMARK 500 ASP B 242 77.58 -102.87 REMARK 500 LEU B 248 -169.83 -108.72 REMARK 500 ALA B 251 -16.72 55.54 REMARK 500 LYS B 258 64.00 -117.60 REMARK 500 PHE B 274 7.68 -57.27 REMARK 500 THR B 343 32.06 -95.84 REMARK 500 ASP B 344 74.00 -105.54 REMARK 500 GLU B 384 -65.20 -94.25 REMARK 500 ARG H 11 26.67 25.17 REMARK 500 ARG H 11 7.59 30.22 REMARK 500 ARG H 14 106.36 -32.07 REMARK 500 ARG H 14 108.51 -27.84 REMARK 500 ILE H 15 61.73 21.34 REMARK 500 ILE H 15 62.63 16.23 REMARK 500 ALA H 17 -42.24 -23.20 REMARK 500 ALA H 17 -47.78 -16.44 REMARK 500 GLN H 18 88.23 -43.46 REMARK 500 GLN H 18 68.46 -54.80 REMARK 500 SER H 19 -103.27 -76.54 REMARK 500 SER H 19 -124.93 -66.89 REMARK 500 LEU H 21 -66.92 -150.13 REMARK 500 LEU H 21 -57.19 165.60 REMARK 500 SER H 25 -135.25 -168.58 REMARK 500 SER H 25 -137.40 -167.57 REMARK 500 PHE H 26 -17.21 -175.63 REMARK 500 PHE H 26 -36.56 -154.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DP4 RELATED DB: PDB REMARK 900 ATRIAL NATRIURETIC PEPTIDE RECEPTOR APO-FORM DBREF 1T34 A 1 435 UNP P18910 ANPA_RAT 29 463 DBREF 1T34 B 1 435 UNP P18910 ANPA_RAT 29 463 DBREF 1T34 H 7 27 UNP P01161 ANF_RAT 129 149 SEQRES 1 A 435 SER ASP LEU THR VAL ALA VAL VAL LEU PRO LEU THR ASN SEQRES 2 A 435 THR SER TYR PRO TRP SER TRP ALA ARG VAL GLY PRO ALA SEQRES 3 A 435 VAL GLU LEU ALA LEU ALA ARG VAL LYS ALA ARG PRO ASP SEQRES 4 A 435 LEU LEU PRO GLY TRP THR VAL ARG MET VAL LEU GLY SER SEQRES 5 A 435 SER GLU ASN ALA ALA GLY VAL CYS SER ASP THR ALA ALA SEQRES 6 A 435 PRO LEU ALA ALA VAL ASP LEU LYS TRP GLU HIS SER PRO SEQRES 7 A 435 ALA VAL PHE LEU GLY PRO GLY CYS VAL TYR SER ALA ALA SEQRES 8 A 435 PRO VAL GLY ARG PHE THR ALA HIS TRP ARG VAL PRO LEU SEQRES 9 A 435 LEU THR ALA GLY ALA PRO ALA LEU GLY ILE GLY VAL LYS SEQRES 10 A 435 ASP GLU TYR ALA LEU THR THR ARG THR GLY PRO SER HIS SEQRES 11 A 435 VAL LYS LEU GLY ASP PHE VAL THR ALA LEU HIS ARG ARG SEQRES 12 A 435 LEU GLY TRP GLU HIS GLN ALA LEU VAL LEU TYR ALA ASP SEQRES 13 A 435 ARG LEU GLY ASP ASP ARG PRO CYS PHE PHE ILE VAL GLU SEQRES 14 A 435 GLY LEU TYR MET ARG VAL ARG GLU ARG LEU ASN ILE THR SEQRES 15 A 435 VAL ASN HIS GLN GLU PHE VAL GLU GLY ASP PRO ASP HIS SEQRES 16 A 435 TYR PRO LYS LEU LEU ARG ALA VAL ARG ARG LYS GLY ARG SEQRES 17 A 435 VAL ILE TYR ILE CYS SER SER PRO ASP ALA PHE ARG ASN SEQRES 18 A 435 LEU MET LEU LEU ALA LEU ASN ALA GLY LEU THR GLY GLU SEQRES 19 A 435 ASP TYR VAL PHE PHE HIS LEU ASP VAL PHE GLY GLN SER SEQRES 20 A 435 LEU LYS SER ALA GLN GLY LEU VAL PRO GLN LYS PRO TRP SEQRES 21 A 435 GLU ARG GLY ASP GLY GLN ASP ARG SER ALA ARG GLN ALA SEQRES 22 A 435 PHE GLN ALA ALA LYS ILE ILE THR TYR LYS GLU PRO ASP SEQRES 23 A 435 ASN PRO GLU TYR LEU GLU PHE LEU LYS GLN LEU LYS LEU SEQRES 24 A 435 LEU ALA ASP LYS LYS PHE ASN PHE THR VAL GLU ASP GLY SEQRES 25 A 435 LEU LYS ASN ILE ILE PRO ALA SER PHE HIS ASP GLY LEU SEQRES 26 A 435 LEU LEU TYR VAL GLN ALA VAL THR GLU THR LEU ALA GLN SEQRES 27 A 435 GLY GLY THR VAL THR ASP GLY GLU ASN ILE THR GLN ARG SEQRES 28 A 435 MET TRP ASN ARG SER PHE GLN GLY VAL THR GLY TYR LEU SEQRES 29 A 435 LYS ILE ASP ARG ASN GLY ASP ARG ASP THR ASP PHE SER SEQRES 30 A 435 LEU TRP ASP MET ASP PRO GLU THR GLY ALA PHE ARG VAL SEQRES 31 A 435 VAL LEU ASN TYR ASN GLY THR SER GLN GLU LEU MET ALA SEQRES 32 A 435 VAL SER GLU HIS LYS LEU TYR TRP PRO LEU GLY TYR PRO SEQRES 33 A 435 PRO PRO ASP VAL PRO LYS CYS GLY PHE ASP ASN GLU ASP SEQRES 34 A 435 PRO ALA CYS ASN GLN ASP SEQRES 1 B 435 SER ASP LEU THR VAL ALA VAL VAL LEU PRO LEU THR ASN SEQRES 2 B 435 THR SER TYR PRO TRP SER TRP ALA ARG VAL GLY PRO ALA SEQRES 3 B 435 VAL GLU LEU ALA LEU ALA ARG VAL LYS ALA ARG PRO ASP SEQRES 4 B 435 LEU LEU PRO GLY TRP THR VAL ARG MET VAL LEU GLY SER SEQRES 5 B 435 SER GLU ASN ALA ALA GLY VAL CYS SER ASP THR ALA ALA SEQRES 6 B 435 PRO LEU ALA ALA VAL ASP LEU LYS TRP GLU HIS SER PRO SEQRES 7 B 435 ALA VAL PHE LEU GLY PRO GLY CYS VAL TYR SER ALA ALA SEQRES 8 B 435 PRO VAL GLY ARG PHE THR ALA HIS TRP ARG VAL PRO LEU SEQRES 9 B 435 LEU THR ALA GLY ALA PRO ALA LEU GLY ILE GLY VAL LYS SEQRES 10 B 435 ASP GLU TYR ALA LEU THR THR ARG THR GLY PRO SER HIS SEQRES 11 B 435 VAL LYS LEU GLY ASP PHE VAL THR ALA LEU HIS ARG ARG SEQRES 12 B 435 LEU GLY TRP GLU HIS GLN ALA LEU VAL LEU TYR ALA ASP SEQRES 13 B 435 ARG LEU GLY ASP ASP ARG PRO CYS PHE PHE ILE VAL GLU SEQRES 14 B 435 GLY LEU TYR MET ARG VAL ARG GLU ARG LEU ASN ILE THR SEQRES 15 B 435 VAL ASN HIS GLN GLU PHE VAL GLU GLY ASP PRO ASP HIS SEQRES 16 B 435 TYR PRO LYS LEU LEU ARG ALA VAL ARG ARG LYS GLY ARG SEQRES 17 B 435 VAL ILE TYR ILE CYS SER SER PRO ASP ALA PHE ARG ASN SEQRES 18 B 435 LEU MET LEU LEU ALA LEU ASN ALA GLY LEU THR GLY GLU SEQRES 19 B 435 ASP TYR VAL PHE PHE HIS LEU ASP VAL PHE GLY GLN SER SEQRES 20 B 435 LEU LYS SER ALA GLN GLY LEU VAL PRO GLN LYS PRO TRP SEQRES 21 B 435 GLU ARG GLY ASP GLY GLN ASP ARG SER ALA ARG GLN ALA SEQRES 22 B 435 PHE GLN ALA ALA LYS ILE ILE THR TYR LYS GLU PRO ASP SEQRES 23 B 435 ASN PRO GLU TYR LEU GLU PHE LEU LYS GLN LEU LYS LEU SEQRES 24 B 435 LEU ALA ASP LYS LYS PHE ASN PHE THR VAL GLU ASP GLY SEQRES 25 B 435 LEU LYS ASN ILE ILE PRO ALA SER PHE HIS ASP GLY LEU SEQRES 26 B 435 LEU LEU TYR VAL GLN ALA VAL THR GLU THR LEU ALA GLN SEQRES 27 B 435 GLY GLY THR VAL THR ASP GLY GLU ASN ILE THR GLN ARG SEQRES 28 B 435 MET TRP ASN ARG SER PHE GLN GLY VAL THR GLY TYR LEU SEQRES 29 B 435 LYS ILE ASP ARG ASN GLY ASP ARG ASP THR ASP PHE SER SEQRES 30 B 435 LEU TRP ASP MET ASP PRO GLU THR GLY ALA PHE ARG VAL SEQRES 31 B 435 VAL LEU ASN TYR ASN GLY THR SER GLN GLU LEU MET ALA SEQRES 32 B 435 VAL SER GLU HIS LYS LEU TYR TRP PRO LEU GLY TYR PRO SEQRES 33 B 435 PRO PRO ASP VAL PRO LYS CYS GLY PHE ASP ASN GLU ASP SEQRES 34 B 435 PRO ALA CYS ASN GLN ASP SEQRES 1 H 21 CYS PHE GLY GLY ARG ILE ASP ARG ILE GLY ALA GLN SER SEQRES 2 H 21 GLY LEU GLY CYS ASN SER PHE ARG MODRES 1T34 ASN A 13 ASN GLYCOSYLATION SITE MODRES 1T34 ASN A 395 ASN GLYCOSYLATION SITE MODRES 1T34 ASN B 13 ASN GLYCOSYLATION SITE MODRES 1T34 ASN B 395 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET CL A 600 1 HET CL B 601 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 8(C8 H15 N O6) FORMUL 8 CL 2(CL 1-) HELIX 1 1 SER A 19 ALA A 36 1 18 HELIX 2 2 THR A 63 SER A 77 1 15 HELIX 3 3 CYS A 86 ARG A 101 1 16 HELIX 4 4 ALA A 111 VAL A 116 1 6 HELIX 5 5 SER A 129 LEU A 144 1 16 HELIX 6 6 ARG A 162 ASN A 180 1 19 HELIX 7 7 ASP A 194 GLY A 207 1 14 HELIX 8 8 SER A 215 GLY A 230 1 16 HELIX 9 9 GLN A 266 PHE A 274 1 9 HELIX 10 10 ASN A 287 PHE A 305 1 19 HELIX 11 11 GLY A 312 LYS A 314 5 3 HELIX 12 12 ASN A 315 GLN A 338 1 24 HELIX 13 13 ASP A 344 TRP A 353 1 10 HELIX 14 14 SER B 19 ALA B 36 1 18 HELIX 15 15 THR B 63 SER B 77 1 15 HELIX 16 16 CYS B 86 ARG B 101 1 16 HELIX 17 17 ALA B 111 VAL B 116 5 6 HELIX 18 18 SER B 129 LEU B 144 1 16 HELIX 19 19 ARG B 162 LEU B 179 1 18 HELIX 20 20 ASP B 192 ASP B 194 5 3 HELIX 21 21 HIS B 195 GLY B 207 1 13 HELIX 22 22 SER B 215 ALA B 229 1 15 HELIX 23 23 GLN B 266 PHE B 274 1 9 HELIX 24 24 ASN B 287 PHE B 305 1 19 HELIX 25 25 GLY B 312 LYS B 314 5 3 HELIX 26 26 ASN B 315 GLN B 338 1 24 HELIX 27 27 ASP B 344 TRP B 353 1 10 SHEET 1 A 5 THR A 45 SER A 52 0 SHEET 2 A 5 ASP A 2 LEU A 9 1 N VAL A 7 O VAL A 49 SHEET 3 A 5 VAL A 80 LEU A 82 1 O VAL A 80 N ALA A 6 SHEET 4 A 5 LEU A 104 THR A 106 1 O LEU A 105 N PHE A 81 SHEET 5 A 5 THR A 123 ARG A 125 1 O THR A 124 N LEU A 104 SHEET 1 B 8 THR A 182 PHE A 188 0 SHEET 2 B 8 GLN A 149 ALA A 155 1 N VAL A 152 O ASN A 184 SHEET 3 B 8 VAL A 209 CYS A 213 1 O TYR A 211 N LEU A 153 SHEET 4 B 8 VAL A 237 LEU A 241 1 O PHE A 239 N ILE A 210 SHEET 5 B 8 ALA A 277 TYR A 282 1 O LYS A 278 N HIS A 240 SHEET 6 B 8 PHE A 376 MET A 381 -1 O TRP A 379 N ILE A 279 SHEET 7 B 8 PHE A 388 TYR A 394 -1 O ARG A 389 N ASP A 380 SHEET 8 B 8 LEU A 401 ALA A 403 -1 O MET A 402 N ASN A 393 SHEET 1 C 2 ARG A 355 GLY A 359 0 SHEET 2 C 2 GLY A 362 ILE A 366 -1 O GLY A 362 N GLY A 359 SHEET 1 D 5 THR B 45 SER B 52 0 SHEET 2 D 5 ASP B 2 LEU B 9 1 N LEU B 3 O ARG B 47 SHEET 3 D 5 VAL B 80 LEU B 82 1 O LEU B 82 N ALA B 6 SHEET 4 D 5 LEU B 104 THR B 106 1 O LEU B 105 N PHE B 81 SHEET 5 D 5 THR B 123 ARG B 125 1 O THR B 124 N LEU B 104 SHEET 1 E 8 THR B 182 PHE B 188 0 SHEET 2 E 8 GLN B 149 ALA B 155 1 N VAL B 152 O ASN B 184 SHEET 3 E 8 VAL B 209 CYS B 213 1 O TYR B 211 N LEU B 153 SHEET 4 E 8 VAL B 237 LEU B 241 1 O PHE B 239 N ILE B 210 SHEET 5 E 8 ALA B 277 TYR B 282 1 O ILE B 280 N HIS B 240 SHEET 6 E 8 PHE B 376 ASP B 380 -1 O TRP B 379 N ILE B 279 SHEET 7 E 8 ARG B 389 TYR B 394 -1 O VAL B 391 N LEU B 378 SHEET 8 E 8 LEU B 401 ALA B 403 -1 O MET B 402 N ASN B 393 SHEET 1 F 2 ARG B 355 GLY B 359 0 SHEET 2 F 2 GLY B 362 ILE B 366 -1 O LEU B 364 N PHE B 357 SSBOND 1 CYS A 60 CYS A 86 1555 1555 2.06 SSBOND 2 CYS A 164 CYS A 213 1555 1555 2.06 SSBOND 3 CYS B 60 CYS B 86 1555 1555 2.06 SSBOND 4 CYS B 164 CYS B 213 1555 1555 2.06 SSBOND 5 CYS H 7 CYS H 23 1555 1555 2.04 LINK ND2 ASN A 13 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN A 395 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN B 13 C1 NAG E 1 1555 1555 1.44 LINK ND2 ASN B 395 C1 NAG F 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 CISPEP 1 GLY A 83 PRO A 84 0 -0.38 CISPEP 2 GLY B 83 PRO B 84 0 -1.62 CRYST1 100.131 100.131 259.803 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009987 0.005766 0.000000 0.00000 SCALE2 0.000000 0.011532 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003849 0.00000